| |
| |
SPOT ON
|
| |
PSA-Screening for Prostate Cancer? |
| |
| |
QUESTIONABLE THERAPY
|
| |
Corticosteroid and Long-Acting Beta Antagonist as Fixed Combination for COPD |
| |
| |
NEW ON THE MARKET
|
| |
Vardenafil (LEVITRA): Phosphodiesterase Inhibitor No. 3 |
| |
| |
REVIEW
|
| |
Treatment of Atopic Dermatitis (I) |
| |
| |
a-t-READERS’ QUESTIONS AND COMMENTS
|
 |
Does Acarbose (GLUCOBAY) Prevent Myocardial Infarction?
Dipyrone (e.g. NOVALGIN): Warnings Still Valid? |
| |
| |
IN BRIEF
|
| |
Prevention of Cardiovascular Events by Atorvastatin (SORTIS)
Imatinib (GLIVEC) for Newly Diagnosed Chronic Myeloid Leukemia
TRIZIVIR Arm of Clinical Study Stopped
Antimycotic Fluconazole More Cheaply Available
Botulinum Toxin (BOTOX) Against Wrinkles?
Erratum |
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Burning Tongue Sensation due to REMERON Orally Disintegrating Tablets |
| |
| |
SIDE EFFECTS
|
| |
Optic Neuropathy With Infliximab (REMICADE)
Bufexamac (e.g. PARFENAC): Rapid Sensitization |
| |